3 suspended. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Suspended 3 |
| Phase 2 | 2 | Suspended 2 |
Follow Pet Scan: new trials by email Literature Review of Pet Scan trials Research Report on Pet Scan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer Biospecimen Collection, Cemiplimab, Computed Tomography - Eyelid Squamous Cell Carcinoma, Recurrent Eyelid Squamous Cell Carcinoma | Phase 3 | Suspended | National Cancer Institute (NCI) | 420 | 2025-02-18 | 2026-10-20 |
| Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial Atezolizumab, Biospecimen Collection, Computed Tomography - Extensive Stage Lung Small Cell Carcinoma | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 138 | 2021-01-07 | 2026-10-29 |
| Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery Biospecimen Collection, Carboplatin, Computed Tomography - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 278 | 2019-05-03 | 2026-10-22 |
Adenocarcinoma Of Esophagus (1)
National Cancer Institute (NCI) (3)
United States (3) · Australia (1) · Canada (1)
Jennifer R Eads (1) · Neil D Gross (1) · Quynh-Nhu Nguyen (1)
U10CA180868 (2), U10CA180820 (1)